Compared to MCF-7, both the upregulation of CD44+CD24–/low subpopulation ratio and IC50 of adriamycin indicated that breast cancer stem cells displaying chemoresistance would also play an important role in tamoxifen resistance. Here, CD44 is linked to breast carcinoma.